Ryan Fleming
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Oncology top 5%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 18
- Oncology 16
- HER2/EGFR in Cancer Research 13
- Co-authors
- Changshou Gao (20 shared papers)Nazzareno Dimasi (20 shared papers)Herren Wu (18 shared papers)Binyam Bezabeh (12 shared papers)Steven Coats (3 shared papers)Shenlan Mao (6 shared papers)R. James Christie (4 shared papers)Leslie Wetzel (4 shared papers)
- Journals
- Cancer Research (5 papers)mAbs (4 papers)Applied Physics Letters (2 papers)Science Translational Medicine (2 papers)Chemical Physics Letters (2 papers)
- Partner nations
- United StatesGermanySouth Korea
In The Last Decade
Ryan Fleming
40 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 95
- Radiology, Nuclear Medicine and Imaging 780
- Oncology 657
- Molecular Medicine 83
- Molecular Biology 606
- Immunology 171
Countries citing papers authored by Ryan Fleming
This map shows the geographic impact of Ryan Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Fleming more than expected).
Fields of papers citing papers by Ryan Fleming
This network shows the impact of papers produced by Ryan Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Fleming. The network helps show where Ryan Fleming may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryan Fleming, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 317 | |
| 2 | 2014 | 233 | |
| 3 | 2008 | 128 | |
| 4 | 2015 | 111 | |
| 5 | 2017 | 103 | |
| 6 | 2009 | 80 | |
| 7 | 2017 | 65 | |
| 8 | 2016 | 55 | |
| 9 | 2016 | 46 | |
| 10 | 2014 | 36 | |
| 11 | 2016 | 33 | |
| 12 | 2015 | 26 | |
| 13 | 2018 | 19 | |
| 14 | 2015 | 18 | |
| 15 | 2016 | 18 | |
| 16 | 2019 | 18 | |
| 17 | 2017 | 18 | |
| 18 | 2019 | 16 | |
| 19 | 2023 | 16 | |
| 20 | 2019 | 16 |
About Ryan Fleming
Ryan Fleming is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, Electrical and Electronic Engineering and Atomic and Molecular Physics, and Optics, having authored 44 papers that have together received 1.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (18 papers), HER2/EGFR in Cancer Research (13 papers), Glycosylation and Glycoproteins Research (6 papers), Particle accelerators and beam dynamics (6 papers), Gyrotron and Vacuum Electronics Research (5 papers), Particle Accelerators and Free-Electron Lasers (4 papers), Protein purification and stability (4 papers) and Diamond and Carbon-based Materials Research (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (780 citations), Oncology (657 citations), Molecular Medicine (83 citations), Molecular Biology (606 citations) and Immunology (171 citations). Ryan Fleming has collaborated with scholars based in United States, Germany and South Korea. Frequent co-authors include Changshou Gao, Nazzareno Dimasi, Herren Wu, Binyam Bezabeh, Steven Coats, Shenlan Mao, R. James Christie, Leslie Wetzel, Dorin Toader and Peter A. Kiener. Their work appears in journals such as Cancer Research, mAbs, Applied Physics Letters, Science Translational Medicine and Chemical Physics Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.